Resort-style clothing maker Oxford Industries Inc. on Wednesday offered up mixed second-quarter results and third-quarter ...

The "natural yet glamorous" celebration featured a family-style Italian dinner and chocolate wedding cake with brown butter ...

Our Grant Me Hope child this week is 15-year-old Lilly, who loves being in the water and swimming. According to the Michigan Adoption Resource Exchange, Lilly also has a love of wildlife and wants to ...

Eli Lilly and Co LLY has entered into a $1.3 billion deal with Superluminal Medicines to develop small-molecule drugs through artificial intelligence (AI) to treat obesity and other cardiometabolic ...

Eli Lilly’s (LLY) Zepbound has outshone Novo Nordisk’s Wegovy, achieving superior weight-loss results in clinical trials. The weight-loss drug market is highly competitive, driven by the success of ...

If at first you don’t succeed, try, try again. That seems to be the strategy behind a new lawsuit from Texas Attorney General Ken Paxton and Health Choice Alliance accusing Eli Lilly of “incentivizing ...

The weight-loss drug market has become a battleground, ignited by the runaway success of Novo Nordisk’s (NYSE:NVO) Ozempic and Wegovy. These injectable GLP-1 receptor agonists have transformed obesity ...

Superluminal to receive payments, equity investment, royalties Lilly, Novo pursuing GPCR-targeting drugs for obesity Superluminal's lead candidate not part of deal with Lilly Aug 14 (Reuters) - Eli ...

We recently published 10 Stocks On Jim Cramer’s Radar Including Big Tech Firms. Eli Lilly and Company (NYSE:LLY) is one of the stocks Jim Cramer recently discussed. Eli Lilly and Company (NYSE:LLY) ...

Having backed Superluminal Medicines’ series A last year, Eli Lilly has now signed a $1.3 billion pact with the G protein-coupled receptor biotech. The deal will see Superluminal use its GPCR platform ...

Jenna Sundel is a Newsweek reporter based in New Jersey. Her focus is reporting on breaking news. She has in-depth knowledge of crime and courts. Jenna joined Newsweek in 2024. She previously worked ...

Share on Pinterest GLP-1 drugmaker Eli Lilly’s new weight loss pill orforglipron showed meaningful weight loss results in a recent clinical trial. Scott Olson/Getty Images Eli Lilly’s new oral GLP-1 ...